Collaborating for the Advancement of Interdisciplinary Research in Benign Urology
2-year award includes: (1) 10 biological samples from any body system (2) All costs including tissue preservation reagents and shipping costs (3) Letter of support and budget justification help for required subsequent NIH grant application(s) and (4) Technical support for tissue procurement protocol design. Open to ESIs OR established investigators transitioning to using human biospecimens. [Application deadline: 11/1/26.]
Up to $100K in total costs for 20 weeks with the potential to receive $1.28m for 1y to support the development of commercially viable, clinically focused medical device technologies that prevent, diagnose, or treat disorders of the nervous system. [Preproposal deadline: 10/21/26.]
Up to $450K (direct costs) per year for Clinical Trial Evaluation Units and an additional $2m (direct costs) for a Network Coordinating Center to evaluate interventions for emerging and chronic infections. [Deadline: 11/10/26.]
Up to $12m / y in direct costs for 7 years to support a program aiming to design, implement, and manage clinical research that addresses pivotal clinical questions related to antimicrobial resistance (AMR). [Deadline: 11/10/26.]
Up to $225K / y in direct costs for 5y to support early-stage clinician-scientists in advancing their research and leadership skills in their specialty and in the broader field of aging research. [Deadline: 11/10/26.]
Up to $125K / y for 2y for early-career clinician-scientists trained in medical or surgical specialties to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects. [Expires 7/17/2028.]
Up to three years support for early-stage postdoctoral scholars to fund rigorous, mentored scientific research and career development. [Expires 7/13/29.]
To support projects aimed toward commercialization that are led by an academic-industrial partnership primarily focusing on novel data integration and/or new AI model development. The goal is to develop and de-risk novel AI technologies through collaboration, preparing them for future commercialization, adoption, and use of a CDS tool(s). [Deadline: 10/19/26.]
Supports the creation of a Validation Center to serve as a dedicated hub for the comprehensive evaluation and characterization of AI-enabled, image-based, multimodal CDS tools developed by the PRIMED-AI Consortium, to ensure these tools are reliable, reproducible, and generalizable. [Deadline: 10/2/26.]
To support the design, development, and preliminary validation of robust frameworks for the application of multimodal-artificial intelligence (AI) models for clinical use. Frameworks developed through these awards would populate a "playbook", defined as a collection of actionable guidelines, standardized protocols, and/or standard operating procedures (SOPs) for reliable and effective development and deployment of multimodal AI tools. [Deadline: 10/9/26.]
